Nuvectis
Fort Lee, US · Founded 2020 · 1 known investors
Nuvectis is a biopharmaceutical company developing oral small molecule therapies for cancer, including NXP900, an SRC Family Kinase inhibitor, and NXP800, a GCN2 activator being evaluated in solid tumors such as ovarian cancer and cholangiocarcinoma. Its drug candidates are in early-stage clinical trials for patients with advanced solid tumors.
Founders & leadership
JO
James OlivieroNamed on SEC filing
EP
Enrique PoradosuNamed on SEC filing
MK
Matthew KaplanNamed on SEC filing
MC
Michael CarsonNamed on SEC filing
KH
Kenneth HobermanNamed on SEC filing
RB
Ron BentsurNamed on SEC filing
SS
Shay ShemeshNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$15.9M disclosed across 1 of 3 rounds · 2022–2026
▶$15.9MraisedAug 2022 · 19 investors · BiotechnologyRule 506(b)
▶$15.9MraisedAug 2022 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James OlivieroDirector
- Enrique PoradosuExecutive Officer
- Matthew KaplanDirector
- Michael CarsonExecutive Officer
- Kenneth HobermanDirector
- Ron BentsurExecutive Officer, Director
- Shay ShemeshExecutive Officer
- Offering amount
- $15.9M
- Amount sold
- $15.9M
- Sales commissions
- $1.4M
- Placement agents
- H.C. Wainwright & Co.
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Nuvectis do?
- Nuvectis is a biopharmaceutical company developing oral small molecule therapies for cancer, including NXP900, an SRC Family Kinase inhibitor, and NXP800, a GCN2 activator being evaluated in solid tumors such as ovarian cancer and cholangiocarcinoma. Its drug candidates are in early-stage clinical trials for patients with advanced solid tumors.
- Who are Nuvectis's investors?
- Nuvectis's investors include Pontifax Venture Capital.
- How much funding has Nuvectis raised?
- Nuvectis has disclosed $15.9M raised across 1 of its 3 known rounds.
- Where is Nuvectis headquartered?
- Nuvectis is headquartered in Fort Lee, US.